Showing results (151-160 of 244) with videos related to

Sort By:
Pageof 25
MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports|July 24, 2020
Testing and Clinical Management of Health Care Personnel Potentially Exposed to Hepatitis C Virus - CDC Guidance, United States, 2020Anne C Moorman, Marie A de Perio, Ronald Goldschmidt, et al.
Digestive Diseases and Sciences|May 25, 2016
Prevalence of Renal Impairment and Associated Conditions Among HCV-Infected Persons in the Chronic Hepatitis Cohort Study (CHeCS)Anne C Moorman, Xin Tong, Philip R Spradling, et al.
Infectious Diseases and Therapy|April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated AnalysisCurtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 10, 2012
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalencePhilip R Spradling, Loralee Rupp, Anne C Moorman, et al.
Digestive Diseases and Sciences|October 2, 2017
A Point System to Forecast Hepatocellular Carcinoma Risk Before and After Treatment Among Persons with Chronic Hepatitis CJian Xing, Philip R Spradling, Anne C Moorman, et al.
Infectious Disease Clinics of North America|May 21, 2018
Long-Term Liver Disease, Treatment, and Mortality Outcomes Among 17,000 Persons Diagnosed with Chronic Hepatitis C Virus Infection: Current Chronic Hepatitis Cohort Study Status and Review of FindingsAnne C Moorman, Loralee B Rupp, Stuart C Gordon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 31, 2018
Mortality Among Patients With Chronic Hepatitis B Infection: The Chronic Hepatitis Cohort Study (CHeCS)Danae Bixler, Yuna Zhong, Kathleen N Ly, et al.
Hepatology (Baltimore, Md.)|January 2, 2010
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damageI-Chin Wu, Ching-Lung Lai, Steven-Huy Bui Han, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 16, 2015
Grazoprevir, Elbasvir, and Ribavirin for Chronic Hepatitis C Virus Genotype 1 Infection After Failure of Pegylated Interferon and Ribavirin With an Earlier-Generation Protease Inhibitor: Final 24-Week Results From C-SALVAGEMaria Buti, Stuart C Gordon, Eli Zuckerman, et al.
Alimentary Pharmacology & Therapeutics|June 30, 2020
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practicesZobair M Younossi, Kathleen E Corey, Naim Alkhouri, et al.
Pageof 25